167 related articles for article (PubMed ID: 35039004)
21. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
[TBL] [Abstract][Full Text] [Related]
22. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.
Serrano M; Lage P; Belga S; Filipe B; Francisco I; Rodrigues P; Fonseca R; Chaves P; Claro I; Albuquerque C; Pereira AD
Fam Cancer; 2012 Dec; 11(4):571-8. PubMed ID: 22776989
[TBL] [Abstract][Full Text] [Related]
23. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
Heald B; Plesec T; Liu X; Pai R; Patil D; Moline J; Sharp RR; Burke CA; Kalady MF; Church J; Eng C
J Clin Oncol; 2013 Apr; 31(10):1336-40. PubMed ID: 23401454
[TBL] [Abstract][Full Text] [Related]
24. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ
Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of microsatellite instability in colorectal cancer.
Kloor M; Staffa L; Ahadova A; von Knebel Doeberitz M
Langenbecks Arch Surg; 2014 Jan; 399(1):23-31. PubMed ID: 24048684
[TBL] [Abstract][Full Text] [Related]
26. Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?
Brazowski E; Rozen P; Pel S; Samuel Z; Solar I; Rosner G
Fam Cancer; 2012 Jun; 11(2):249-57. PubMed ID: 22246243
[TBL] [Abstract][Full Text] [Related]
27. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
28. Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort.
González ML; Causada-Calo N; Santino JP; Dominguez-Valentin M; Ferro FA; Sammartino I; Kalfayan PG; Verzura MA; Piñero TA; Cajal AR; Pavicic W; Vaccaro C
Fam Cancer; 2018 Jul; 17(3):395-402. PubMed ID: 29128931
[TBL] [Abstract][Full Text] [Related]
29. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
30. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
[TBL] [Abstract][Full Text] [Related]
31. Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnostics.
Bläker H; Haupt S; Morak M; Holinski-Feder E; Arnold A; Horst D; Sieber-Frank J; Seidler F; von Winterfeld M; Alwers E; Chang-Claude J; Brenner H; Roth W; Engel C; Löffler M; Möslein G; Schackert HK; Weitz J; Perne C; Aretz S; Hüneburg R; Schmiegel W; Vangala D; Rahner N; Steinke-Lange V; Heuveline V; von Knebel Doeberitz M; Ahadova A; Hoffmeister M; Kloor M;
Int J Cancer; 2020 Nov; 147(10):2801-2810. PubMed ID: 32875553
[TBL] [Abstract][Full Text] [Related]
32. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
33. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
34. Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
Kloth M; Ruesseler V; Engel C; Koenig K; Peifer M; Mariotti E; Kuenstlinger H; Florin A; Rommerscheidt-Fuss U; Koitzsch U; Wodtke C; Ueckeroth F; Holzapfel S; Aretz S; Propping P; Loeffler M; Merkelbach-Bruse S; Odenthal M; Friedrichs N; Heukamp LC; Zander T; Buettner R
Gut; 2016 Aug; 65(8):1296-305. PubMed ID: 26001389
[TBL] [Abstract][Full Text] [Related]
35. High endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer.
Pfuderer PL; Ballhausen A; Seidler F; Stark HJ; Grabe N; Frayling IM; Ager A; von Knebel Doeberitz M; Kloor M; Ahadova A
Br J Cancer; 2019 Aug; 121(5):395-404. PubMed ID: 31358939
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
37. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
38. The evolving role of microsatellite instability in colorectal cancer: A review.
Gelsomino F; Barbolini M; Spallanzani A; Pugliese G; Cascinu S
Cancer Treat Rev; 2016 Dec; 51():19-26. PubMed ID: 27838401
[TBL] [Abstract][Full Text] [Related]
39. Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital.
Kim MH; Kim DW; Lee HS; Bang SK; Seo SH; Park KU; Oh HK; Kang SB
Cancer Res Treat; 2023 Jan; 55(1):179-188. PubMed ID: 35313100
[TBL] [Abstract][Full Text] [Related]
40. Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome?
Song T; Kim MK; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():208-12. PubMed ID: 26298861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]